Contact

Click here for a confidential contact or call:

1-212-350-2774

Archive

Page 44 of 51

Medicare Advantage Plan Loses Members, Responds with Plans to Raise Risk Adjustment Scores

Posted  09/22/15
By Tim McCormack and Molly Knobler (published on The Compliance & Ethics Blog) Modern Healthcare recently reported that although enrollment in the Medicare Managed Care Program (also known as Medicare Advantage or Medicare Part C) has grown by 8% on average since 2010, several top Medicare Advantage Plans are losing membership.  Highmark, Blue Cross and Blue Shield of North Carolina, HealthNow New York, Wellcare...

Stark Law Enforcement Trend: Hospital and Individual Physician Settle Allegations of Stark Law Violations and Illegal Upcoding

Posted  09/18/15
By Tim McCormack and Molly Knobler (published on SCCE’s Compliance and Ethics Blog) The Department of Justice’s (“DOJ”) recent string of victories against hospitals that have (allegedly) paid illegal inducements to employed physicians continues.  On September 4, 2015, DOJ settled two False Claims Act (“FCA”) suits with Columbus Regional Healthcare System (“Columbus”) and Dr. Andrew Pippas. ...

DOJ Catch of the Week -- Alive Hospice

Posted  09/11/15
By the C|C Whistleblower Lawyer Team This week's Department of Justice "Catch of the Week" goes to Tennessee-based non-profit hospice care provider Alive Hospice, Inc. Yesterday, the DOJ announced the company paid roughly $1.5 million to reimburse the government for alleged violations of the False Claims Act through overbilling of Medicare and TennCare for hospice services. See DOJ Press Release.   The...

Constantine Cannon And Department of Justice Continue Joint Pursuit Against California Sleep-Clinic Chain

Posted  09/4/15
By Jessica T. Moore Constantine Cannon LLP has filed an amended complaint on behalf of a whistleblower alleging multi-faceted fraud on the part of Bay Sleep Clinic and its owners and operators, and billing company Access Medical Consultants.  The filing in United States ex rel. Dresser v. Qualium Corp., et al, Civil Action No. 12-1745 in the Northern District of California, comes on the same day the United...

Is The FDA Ready For Kim Kardashian And Mutant Head Lice?

Posted  08/31/15
(published on the Huffington Post blog) A pharmaceutical company was recently reprimanded by the FDA for its misleading marketing tactics on an unexpected forum—Kim Kardashian's Instagram feed.  The new mother's failure to address the full safety profile of morning sickness drug, Diclegis, prompted the FDA to issue a warning letter to the drug's manufacturer.  This sort of enforcement is representative of the...

The AseraCare Trial Gears Up and Creates Ripples for Larger Hospice Industry

Posted  08/6/15
By Mary Inman and Ari Yampolsky The issue teed up in the Government's trial against AseraCare cuts to the core of Medicare’s hospice benefit.  A Medicare beneficiary is eligible for hospice care only if two doctors certify that she is “terminally ill.”  This means that her illness will lead to her death within six months, if the illness runs its normal course.  Because Medicare beneficiaries who choose...

As AseraCare Trial Begins, Judge Narrows What Government Can Present to the Jury

Posted  08/5/15
by Mary Inman and Ari Yampolsky Yesterday's AseraCare trial began like all others with the empaneling and swearing in of the jury.  However, unlike juries in other False Claims Act trials, this jury will only be provided with a narrow slice of the evidence.  Judge Bowdre has divided the trial into phases and, in an unusual move, has severely restricted what the Phase One jury will consider. Although there are...

Can Data Bring Reason to Drug Pricing?

Posted  07/24/15
As far as purveyors of all things pharmaceutical go, Walter White isn’t looking so bad these days.  Well, at least his prices were competitive.  With major pharmaceutical companies putting astronomical and ever-increasing price tags on frequently life-saving medications, patients and insurers, including state and federal government payers, are finding themselves looking for new options and opportunities to...

Congress Highlights Medicare Part D Plans’ Failure To Prevent Fraud

Posted  07/16/15
Fraud in the Medicare Part D prescription drug program is getting the attention of not only the Department of Health and Human Services’ Office of the Inspector General (HHS OIG) but also watchdogs on Capitol Hill.  On Tuesday, July 14, 2015, the House of Representatives’ Committee on Energy and Commerce held a hearing to examine two recent reports from HHS OIG examining improper spending in the Medicare Part...

DOJ Enforcement Spotlight -- Cancer Doctor Farid Fata

Posted  07/14/15
By the C|C Whistleblower Lawyer Team Last Friday, the Department of Justice secured a 45-year prison sentence against the now infamous Detroit-area doctor, Farid Fata.  He was also ordered to forfeit $17.6 million of illegal reimbursements he obtained from Medicare and private insurance companies.  This stems from his guilty plea in September 2014 to violating the False Claims Act with a health care fraud scheme...
1 41 42 43 44 45 46 47 51